EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives

Matteo Terrinoni iD, Valerio Caputo iD, Michele Palisciano, Giuseppe Mascellino iD, Sandro Gerli, Alessandro Favilli iD

Genes · 21.06.2026 · 17 (6) · 714

DOI: 10.3390/genes17060714 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 21.06.2026. Verfasst von Matteo Terrinoni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Perugia, 06132 Perugia, Italy. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Biomarkers, Tumor, RNA, Untranslated. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cervical cancer is mainly driven by persistent infection with high-risk human papillomaviruses (HPV), particularly HPV16 and HPV18. Despite advances in cytology, HPV-DNA testing and vaccination, challenges remain in the triage of HPV-positive individuals, prognostic stratification and prediction of treatment response. Non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs and circular RNAs, together with host genetic factors influencing ncRNA expression and emerging lncRNA-encoded peptides, are increasingly recognized as regulators of HPV-associated carcinogenesis. This review summarizes their biological and potential clinical relevance.

Methods

A structured literature search was conducted in PubMed and Scopus. Eligible studies included experimental, clinical, observational, genomic and translational investigations on ncRNA dysregulation, circulating or exosomal ncRNAs, treatment-response signatures, host genetic variation and lncRNA-encoded peptides in HPV-associated cervical precancer and cancer.

Results

HPV oncoproteins can reshape host ncRNA networks through transcriptional and epigenetic mechanisms. Several miRNAs, lncRNAs and circRNAs are involved in cell-cycle control, apoptosis, senescence, epithelial–mesenchymal transition, immune regulation, DNA repair and treatment resistance. Circulating, exosomal and urinary ncRNA signatures have shown diagnostic or prognostic potential in exploratory cohorts. Specific lncRNAs, including ENSG00000267838/lnc-LENG9-5 and lncRNA-EME1, have been associated with chemoradiotherapy response and radioresistance. The lncRNA-encoded peptide TUBORF represents a novel preclinical therapeutic candidate, while genetic variation may further modulate lncRNA function in HPV-related cervical cancer. Conclusions: ncRNAs are promising candidates for risk stratification, non-invasive diagnosis, treatment-response prediction and therapeutic development in HPV-associated cervical disease. However, evidence remains exploratory, requiring prospective multicentre validation and standardized workflows before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsBiomarkers, TumorRNA, UntranslatedPrecancerous ConditionsHumansFemaleMicroRNAsHuman Papillomavirus VirusesRNA, Long Noncoding

Stichwörter der Autor:innen

HPVTUBORFbiomarkerscervical cancerchemoradiotherapy resistancecircular RNAexosomeslncRNAmicroRNAnon-coding RNA

Substanzen

Biomarkers, TumorRNA, UntranslatedMicroRNAsRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Perugia, 06132 Perugia, Italy.
  • Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Department of Obstetrics and Gynecology, "Alto Tevere" Hospital of Città di Castello, USL Umbria 1, 06127 Perugia, Italy.
  • Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Department of Obstetrics and Gynecology, Bufalini Hospital, 47521 Cesena, Italy.
  • Dipartimento PROMISE del Policlinico di Palermo (Promozione della Salute Materno Infantile, di Medicina Interna e Specialistica G. d'Alessandro), 90127 Palermo, Italy.

ORCID-Profile: Matteo Terrinoni, Valerio Caputo, Giuseppe Mascellino, Alessandro Favilli

Zitieren

APA

Terrinoni, M., Caputo, V., Palisciano, M., Mascellino, G., Gerli, S., & Favilli, A. (2026). Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives. Genes, 17(6), 714. https://doi.org/10.3390/genes17060714

Vancouver

Terrinoni M, Caputo V, Palisciano M, Mascellino G, Gerli S, Favilli A. Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives. Genes. 2026;17(6):714. doi:10.3390/genes17060714

BibTeX
@article{Terrinoni2026,
  author = {Terrinoni, Matteo and Caputo, Valerio and Palisciano, Michele and Mascellino, Giuseppe and Gerli, Sandro and Favilli, Alessandro},
  title = {Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {714},
  doi = {10.3390/genes17060714}
}
Kostenlos starten →